Saudi Central Bank boosted its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 89.0% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,782 shares of the medical research company’s stock after acquiring an additional 9,318 shares during the quarter. Saudi Central Bank’s holdings in Agilent Technologies were worth $2,628,000 as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of the business. SHP Wealth Management purchased a new stake in shares of Agilent Technologies during the fourth quarter valued at $26,000. Core Wealth Advisors LLC purchased a new position in Agilent Technologies in the 4th quarter worth about $26,000. Navalign LLC bought a new stake in Agilent Technologies during the 4th quarter valued at about $27,000. Markowski Investments bought a new stake in Agilent Technologies during the 2nd quarter valued at about $27,000. Finally, MV Capital Management Inc. purchased a new stake in Agilent Technologies in the 4th quarter valued at about $28,000.
Analysts Set New Price Targets
A number of equities analysts have recently commented on the stock. Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Robert W. Baird boosted their price target on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a report on Tuesday, May 26th. Barclays increased their price objective on Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a research note on Thursday, August 27th. HSBC reduced their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Finally, Jefferies Financial Group began coverage on Agilent Technologies in a report on Thursday, July 9th. They issued a “hold” rating and a $135.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $170.33.
Agilent Technologies Price Performance
Shares of A opened at $150.60 on Tuesday. The company has a 50 day moving average price of $142.62 and a 200-day moving average price of $128.08. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $163.75. The stock has a market capitalization of $42.46 billion, a PE ratio of 29.65, a PEG ratio of 2.30 and a beta of 1.24. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05.
Agilent Technologies (NYSE:A – Get Free Report) last announced its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The business had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. During the same quarter last year, the firm earned $1.37 EPS. The business’s revenue for the quarter was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 6.2 earnings per share for the current fiscal year.
About Agilent Technologies
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
See Also
- Five stocks we like better than Agilent Technologies
- 3 Under-the-Radar Defense Stocks With Record Backlogs
- This Korea ETF Has Soared, But the Rally May Not Be Over
- Why Guidewire’s Post-Earnings Plunge May Not Last
- Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
